Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT02789384 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

CINSARC Signature and Correlation With Hemotherapy Efficacy in Soft-tissue Sarcomas. A Biomarker Study.

Study acronym: NEOSarcomics
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Interventions: Procedure/Surgery (Other) to Procedure/Surgery (Other) Show 4 more changesShow less
    • Eligibility criteria expanded, about 18 words
    • Secondary endpoints: details revised at 1 of 8 entries
    • Site details revised at 1 of 10 sites
    • Publications: details revised at 1 of 1 entry
  2. Primary completion date: Jan 2025 to Dec 2026
    • Study completion date: Aug 2027 to Dec 2027
    v7
  3. Primary completion date: Apr 2023 to Jan 2025
    • Study completion date: Oct 2025 to Aug 2027
    v6
  4. Primary completion date: Apr 2021 to Apr 2023
    • Study completion date: Oct 2023 to Oct 2025
    v5
  5. Primary completion date: Jan 2019 to Apr 2021
    • Study completion date: Jan 2021 to Oct 2023
    • Site details revised at 7 of 10 sites
    v4
Show 2 earlier versionsHide 2 earlier versions
  1. Primary completion date: Jan 2018 to Jan 2019v3
  2. Trial status: Not Yet Recruiting to Recruiting
    • Primary completion date: Jan 2017 to Jan 2018
    • Site details revised at 10 of 10 sites
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Institut Bergonié
40 trials monitored
See 1 trial at risk
Sarcoma
1,026 trials monitored
See 67 trials at risk
This is a prospective observational biomarker study including patients with non-metastatic, soft-tissue sarcomas (STS) for whom neoadjuvant chemotherapy is considered as the best option by the multidisciplinary sarcoma team of one of the participating centers.
Trial Details
NCT Number NCT02789384
Lead Sponsor Institut Bergonié
Collaborators: National Cancer Institute, France, Ministry of Health, France
Conditions
(from sponsor)		 Soft-tissue Sarcomas
Related terms Sarcoma
Enrollment 205 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov